|
Neuroprotectors
Citations 31-40 of 537 total displayed.
|
Past content
(since Jan 1999):
|
- Articles
Alternate Pathways Preserve Tumor Necrosis Factor- Production After Nuclear Factor- B Inhibition in Neonatal Cerebral Hypoxia–Ischemia
- Cora H. Nijboer, Cobi J. Heijnen, Floris Groenendaal, Frank van Bel, and Annemieke Kavelaars
Stroke published July 23, 2009, doi:10.1161/STROKEAHA.109.560250
[Abstract]
- Articles
Delayed Hypoxic Postconditioning Protects Against Cerebral Ischemia in the Mouse
- Claire Leconte, Emmanuelle Tixier, Thomas Freret, Jérôme Toutain, Romaric Saulnier, Michel Boulouard, Simon Roussel, Pascale Schumann-Bard, and Myriam Bernaudin
Stroke published July 23, 2009, doi:10.1161/STROKEAHA.109.557314
[Abstract]
- Articles
Minocycline and Tissue-Type Plasminogen Activator for Stroke. Assessment of Interaction Potential
- Livia S. Machado, Irina Y. Sazonova, Anna Kozak, Daniel C. Wiley, Azza B. El-Remessy, Adviye Ergul, David C. Hess, Jennifer L. Waller, and Susan C. Fagan
Stroke published July 23, 2009, doi:10.1161/STROKEAHA.109.556852
[Abstract]
- Original Contributions
Faster Recovery of Cerebral Perfusion in SOD1-Overexpressed Rats After Cardiac Arrest and Resuscitation
- Yan Xu, Serguei M. Liachenko, Pei Tang, and Pak H. Chan
Stroke 2009;40:2512-2518; published online before print as doi:10.1161/STROKEAHA.109.548453
[Abstract]
[Full text]
- Original Contributions
Role of Interleukin-1β in Early Brain Injury After Subarachnoid Hemorrhage in Mice
- Takumi Sozen, Reiko Tsuchiyama, Yu Hasegawa, Hidenori Suzuki, Vikram Jadhav, Shigeru Nishizawa, and John H. Zhang
Stroke 2009;40:2519-2525; published online before print as doi:10.1161/STROKEAHA.109.549592
[Abstract]
[Full text]
- Original Contributions
Normobaric Hyperoxia Reduces the Neurovascular Complications Associated With Delayed Tissue Plasminogen Activator Treatment in a Rat Model of Focal Cerebral Ischemia
- Wenlan Liu, Jill Hendren, Xu-Jun Qin, and Ke Jian Liu
Stroke 2009;40:2526-2531; published online before print as doi:10.1161/STROKEAHA.108.545483
[Abstract]
[Full text]
- Original Contributions
Recombinant T Cell Receptor Ligand Treats Experimental Stroke
- Sandhya Subramanian, Bing Zhang, Yasuharu Kosaka, Gregory G. Burrows, Marjorie R. Grafe, Arthur A. Vandenbark, Patricia D. Hurn, and Halina Offner
Stroke 2009;40:2539-2545; published online before print as doi:10.1161/STROKEAHA.108.543991
[Abstract]
[Full text]
- Research Letters
Prior Use of Statins Improves Outcome in Patients With Intracerebral Hemorrhage: Prospective Data from the National Acute Stroke Israeli Surveys (NASIS)
- Ronen R. Leker, Salim T. Khoury, Guy Rafaeli, Roseline Shwartz, Roni Eichel, David Tanne on behalf of the NASIS Investigators
Stroke 2009;40:2581-2584; published online before print as doi:10.1161/STROKEAHA.108.546259
[Abstract]
[Full text]
- Articles
The Erythropoietin NeuroProtective Effect: Assessment in CABG Surgery (TENPEAKS). A Randomized, Double-Blind, Placebo Controlled, Proof-of-Concept Clinical Trial
- Gregory Haljan, Andrew Maitland, Alastair Buchan, Rakesh C. Arora, Michael King, John Haigh, Bruce Culleton, Peter Faris, and David Zygun
Stroke published June 25, 2009, doi:10.1161/STROKEAHA.109.549436
[Abstract]
- Articles
Robust Docosahexaenoic Acid–Mediated Neuroprotection in a Rat Model of Transient, Focal Cerebral Ischemia
- Ludmila Belayev, Larissa Khoutorova, Kristal D. Atkins, and Nicolas G. Bazan
Stroke published June 18, 2009, doi:10.1161/STROKEAHA.109.555979
[Abstract]
|
|
